Participant flow32

How many started, completed or left each group, period by period.

1 to 20 of 32

Period	Milestone	Group	Participants
Overall Study	STARTED	A5 Placebo Q2W	49
Overall Study	STARTED	A5 Placebo QM	50
Overall Study	STARTED	A5 Evolocumab Q2W	50
Overall Study	STARTED	A5 Evolocumab QM	50
Overall Study	STARTED	A20 Placebo Q2W	52
Overall Study	STARTED	A20 Placebo QM	51
Overall Study	STARTED	A20 Evolocumab Q2W	51
Overall Study	STARTED	A20 Evolocumab QM	51
Overall Study	Received Treatment	A5 Placebo Q2W	49
Overall Study	Received Treatment	A5 Placebo QM	50
Overall Study	Received Treatment	A5 Evolocumab Q2W	50
Overall Study	Received Treatment	A5 Evolocumab QM	50
Overall Study	Received Treatment	A20 Placebo Q2W	52
Overall Study	Received Treatment	A20 Placebo QM	51
Overall Study	Received Treatment	A20 Evolocumab Q2W	51
Overall Study	Received Treatment	A20 Evolocumab QM	51
Overall Study	COMPLETED	A5 Placebo Q2W	49
Overall Study	COMPLETED	A5 Placebo QM	50
Overall Study	COMPLETED	A5 Evolocumab Q2W	50
Overall Study	COMPLETED	A5 Evolocumab QM	50

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01953328/flow